Journal of Applied Physiology, Vol 73, Issue 6 2432-2439, Copyright © 1992 by American Physiological Society

ARTICLES

L-NAME enhances pulmonary vasoconstriction without inhibiting EDRF-dependent vasodilation

H. L. Lippton, Q. Hao and A. Hyman
Department of Internal Medicine, Louisiana State University Medical School, New Orleans.

The purpose of the present study was to determine the influence of NG-nitro-L-arginine methyl ester (L-NAME) on pulmonary vascular responses to endothelium-dependent relaxing factor- (EDRF) dependent and EDRF-independent substances in the pulmonary vascular bed of the anesthetized cat. Because pulmonary blood flow and left atrial pressure were kept constant, changes in lobar arterial pressure directly reflect changes in pulmonary vascular resistance. When pulmonary vasomotor tone was actively increased by intralobar infusion of U-46619, intralobar bolus injections of acetylcholine, bradykinin, serotonin, and 5-carboxyamidotryptamine (a serotonin1A receptor agonist) decreased lobar arterial pressure in a dose-related manner. The pulmonary vasodilator response to serotonin, but not to 5-carboxyamidotryptamine, acetylcholine, and bradykinin, was significantly decreased by L-NAME (100 mg/kg i.v.). Administration of ritanserin (0.5 mg/kg i.v.), but not L-arginine (1 g/kg i.v. with 60 mg.kg-1 x min-1 i.v. infusion), reversed the inhibitory effects of L-NAME on the pulmonary vasodilator response to serotonin and abolished the enhanced pulmonary vasoconstrictor response to (+-)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminoproprane hydrochloride (a serotonin2 receptor agonist) after L-NAME administration. In conclusion, the present experiments suggest that L-NAME inhibits the pulmonary vasodilator response to serotonin by increasing the sensitivity of serotonin2 receptor-mediated vasoconstriction and not by inhibiting EDRF formation. Because the pulmonary vasodilator responses to bolus administration of acetylcholine and bradykinin were not inhibited by L-NAME, these data suggest that L-NAME does not appear to be an adequate probe to study the role of endogenous EDRF in the adult feline pulmonary vascular bed in vivo.

This article has been cited by other articles:

				V. Hampl and J. Herget Role of Nitric Oxide in the Pathogenesis of Chronic Pulmonary Hypertension Physiol Rev, October 1, 2000; 80(4): 1337 - 1372. [Abstract] [Full Text] [PDF]

				A. L. Hyman, Q. Hao, A. Tower, P. J. Kadowitz, H. C. Champion, B. Gumusel, and H. Lippton Novel catheterization technique for the in vivo measurement of pulmonary vascular responses in rats Am J Physiol Heart Circ Physiol, April 1, 1998; 274(4): H1218 - H1229. [Abstract] [Full Text] [PDF]

				B. Gumusel, Q. Hao, A. L. Hyman, P. J. Kadowitz, H. C. Champion, J. K. Chang, J. L. Mehta, and H. Lippton Analysis of responses to adrenomedullin-(13---52) in the pulmonary vascular bed of rats Am J Physiol Heart Circ Physiol, April 1, 1998; 274(4): H1255 - H1263. [Abstract] [Full Text] [PDF]